Optimapharm d.d. is a Zagreb-based contract research organization that manages clinical trials for pharmaceutical and biotech companies.
Founded in 2006 in Zagreb, Croatia, Optimapharm offers project management, regulatory, and operational support for clinical trials in areas such as oncology, cardiology, neurology, and rare diseases. It works with clients in more than 40 countries, mainly in Europe and North America, under fixed-price or fee-for-service contracts. Igor Cicak is noted as the company's founder, and on May 12, 2020 The Rohatyn Group acquired the firm from Mezzanine Capital Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in